Pittsburgh-based Allegheny General Hospital joined InVivo Therapeutics' INSPIRE study.
Here are five insights:
1. Dan Altman, MD, Nestor Tomycz, MD, and Terrence Julien, MD, implanted the patient with the Neuro-Spinal Scaffold 21 hours following spinal cord injury.
2. Dr. Julien, co-director of minimally invasive spine surgery, serves as the site's principal investigator.
3. The INSPIRE study now has 16 patients in follow up.
4. Allegheny General Hospital is a part of the Allegheny Health Network, also in Pittsburgh.
5. The INSPIRE study tests the Neuro-Spinal Scaffold's efficacy and safety for complete thoracic AIS A spinal cord injury.